Dopamine/glutamate interactions in Parkinson's disease
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 21 (4) , 393-400
- https://doi.org/10.1016/s0149-7634(96)00043-7
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Bildung und Forschung
This publication has 58 references indexed in Scilit:
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 1991
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+)Neuroscience Letters, 1990
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Neuroleptic malignant syndrome: review and analysis of 115 casesBiological Psychiatry, 1987
- ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?The Lancet, 1986
- Autonomic Deficits in Parkinson's SyndromeArchives of Neurology, 1971